New dissection method could improve lung cancer staging

NCT ID NCT06252129

First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 32 times

Summary

This study tests a standardized technique for finding lymph nodes in lung tissue removed during surgery. Researchers want to see if this method finds more nodes and improves cancer staging. About 160 adults with lung cancer who are having a lobectomy will take part. The goal is to help doctors make better treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Brigham and Womens Hospital

    RECRUITING

    Boston, Massachusetts, 02115, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better lung cancer staging and help more patients get the right treatments after surgery.

What could go wrong

This is an early-stage study focused on technique, not a treatment. It may not improve patient outcomes or change standard practice.

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm Lymphatic Metastasis metastatic malignant neoplasm in the lymph nodes non-small cell lung carcinoma Pathologic Processes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.